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Exposures to asbestos and synthetic fibers remain areas of great concern in the field of occupational
lung disease. Despite extensive study, the health effects associated with fibers remains an area of
substantial controversy. In particular, effects of fibers at relatively low doses, particularly for
mesothelioma, remain a matter of evolving opinion, especially when integrated with the divergence
of opinion on relative pathogenicity of different fiber types. Mechanistic studies continue to provide a
window into pathogenesis and some hope for understanding dose-response relationships at the
lower levels seen in contemporary Western workplaces and the general environment. Changes in
clinical assessment based on use of new chest imaging techniques beyond the traditional plain film
are also an area of evolution and begin to challenge B-reading as the definitive tool for noninvasive
assessment of disease. Public health concerns have to a great extent been transported to the
developing world where there is a strong trend toward increased use of asbestos, although it has
been virtually eliminated from commerce in most developed countries. For nonasbestos fibers, the
major unsettled issues are their relative potencies as carcinogens for the human lung and
mesothelium and the need to sort out the relation between physical and chemical properties of
these fibers and their pathogenicity. The recent discovery of "flock worker's lung" due to synthetic
fibers once again alerts us to emerging diseases associated with new technologies. Key words:
asbestos, asbestosis, chrysotile, man-made mineral fibers, man-made vitreous fibers, mesothelioma,
susceptibility. - Environ Health Perspect 108(suppl 4):665-674 (2000).
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In this article we examine the current state of
knowledge regarding the association of nat-
ural and synthetic fibers with fibrotic and
neoplastic lung disease. It is well established
that inhalation by humans of all forms of
asbestos can cause pleural plaques, pleural
fibrosis, interstitial fibrosis (asbestosis) ofthe
lung parenchyma, carcinoma ofthe lung, and
mesothelioma, but potency and riskvarywith
fiber type and exposure history. Numerous
epidemiology studies ofworkers in produc-
tion, fabrication, and end use (largely con-
struction) have been published, and asbestos
is probably the best studied occupational and
environmental health hazard. However,
important controversies persist, partly because
ofgaps in science and partly because ofdiffer-
ent interpretations ofexisting data. Currently,
the most important controversies concern the
risks from low-level and ambient asbestos
exposure, as well as the magnitude of
mesothelioma risk from chrysotile inhalation.
These issues are critical not only because of
their inherent scientific importance but also
because of their profound implications for
future asbestos use and use constraints, espe-
ciallyfrom an international perspective.
Dust control regulations in developed
nations have become progressively more
demanding compared with the 10-100
fiber/cc exposure concentrations ofthe mid-
20th century. The current U.S. Occupational
Safety and Health Administration permissi-
ble exposure limit (OSHA PEL) is 0.1
fibers/cc, time-weighted average, for all six
fiber types. Although some risk assessments
still predict substantial morbidity at these
levels (1), others suggest the presence of
thresholds for at least asbestosis (2). Thus,
health research objectives have progressed to
focus on the effects of much lower levels of
asbestos fiber exposure, including ambient
exposure in the vicinity of operations that
use or process asbestos.
The major asbestos-exposed cohorts that
continue to be studied for health effects are
construction insulation workers (studied by
Selikoffand colleagues), South Carolina tex-
tileworkers (studied by Dement and NIOSH)
and Quebec miners, millers, and factory
workers (studied by McDonald and others).
The latter two chrysotile-exposed cohorts have
undergone detailed exposure reconstructions.
Within limits, this has facilitated attempts to
examine dose-response relationships and per-
form risk assessments (1). Although all these
cohorts were originally reported onwell before
the 1990s, new information continues to
appear that refines or revises that originally
reported with respect to the associations
between asbestos and disease. As asbestos uses
have been phased out of commerce, many
new fibrous materials have been used as sub-
stitutes, usually before the health hazard
potential has been adequately evaluated.
In this article we discuss asbestos fibers,
zeolites, man-made vitreous (mineral) fibers
(MMVFs), as well as some newer nonvitreous
(organic) synthetic fibers (nylon flock). We
emphasize aspects offibers and health such as
fibrosis and mesothelioma not specifically
addressed elsewhere in this monograph but
cannot completely avoid discussion oflung
cancer, which is addressed more specifically
elsewhere in this monograph. Concluding
remarks address current policy and research
implications of fiber health hazards. The
focus ofdiscussion is on information pub-
lished in the last decade ofthe 20th century.
Nomenclature, Sources,
and Production of Fibers
Asbestos
Asbestos is a commercial term for six different
types of naturally occurring fibrous crystals
(crocidolite, amosite, chrysotile, anthophyl-
lite, tremolite, and actinolite) composed of
hydrated aluminum-magnesium silicates
with varying metal composition. The two
major classes are serpentine (limited to
chrysotile) and amphiboles, which include all
the remaining asbestos fiber types, although
only chrysotile, crocidolite, and amosite have
experienced widespread commercial exploita-
tion. Chrysotile has long relatively flexible
fibers, whereas amphiboles are characterized
by shorter, rigid fibers. Fiber types sometimes
occur in combination, e.g., chrysotile from
Quebec, Canada, typically contains approxi-
mately 1% of tremolite, an amphibole.
Worldwide, about 95% ofasbestos produced
continues to be chrysotile, and total contem-
porary annual production of2.9 million tons
is comparable to that ofthe early 1960s (3).
The former Soviet Union is the leading con-
temporary producer, followed by Quebec,
China, and Brazil.
Man-MadeVitreous Fibers
Man-made vitreous fibers, a large subset of
man-made mineral fibers (MMMFs), are syn-
thetic, vitreous silicate fibers widely used in
present-day insulation and construction indus-
tries in industrialized nations, following the
dedine ofwidespread use ofasbestos materials.
MMVFs are broadly categorized into insula-
tion wools (rock wool and slag wool), glass
fibers (glass wool, continuous glass filaments
and microfibers), and refractory ceramic fibers
(kaolin-wool and other high-temperature insu-
lating fibers). There are over 70 varieties of
synthetic inorganic fibers (4).
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MMVFs are produced from molten rock,
slag, glass, and kaolin clay as well as from
combinations ofsilicon and aluminum oxide.
Processes used in manufacture include
mechanical drawing, blowing threads or
droplets through jets ofsteam, hot air, or
flame, as well as attenuation ofdroplets of
molten liquid by centrifugation. Several addi-
tives including fire retardants, binders, wet-
ting agents, and antifungal agents are often
incorporated in the production processes (5).
The common-purpose insulation wools,
rock, glass, and slag constitute approximately
80% ofMMVFs currently produced and are
widely used for fire protection, acoustic and
thermal insulation, acoustic ceiling tiles and
panels, air-conditioning and ventilation
ducts, and as growing media for horticulture.
Continuous filament glass fibers comprise
about 10-15% of MMVF production and
are used in reinforcement ofcement, plastics,
resins, paper and rubber products, for textiles,
and for electrical insulation. Refractory
ceramic fibers (RCFs) constitute only 1-2%
ofMMVFs and are used in high-temperature
insulation offurnaces and kilns. Other special
purpose glass fibers comprise less than 1% of
production and are used for high-efficiency
thermal insulation in aircraft and aerospace,
high-performance acoustic insulation, and as
battery separation media. They constitute less
than 1% ofMMVFs produced and are used
in aerospace, high-efficiency filtration, and
otherhigh-performance applications (4).
Rock and slag wools were first introduced
in the late 1800s. Fiberglass came into use in
the 1930s and refractory ceramic fibers have
been produced since the 1950s (6). The
industrial processes utilized in MMVF pro-
duction facilities have changed over the years.
In the early years of production, batch
processes involving labor-intensive and hand-
operated production methods as well as
poorly ventilated facilities were common-
place. In addition, dust-suppressing agents
were not used. Hence, workers employed
during this period had high levels offiber
dust exposure. It is also noteworthy that in
the early technological phase, contaminants
such as asbestos, bitumen, pitch, silica, and
formaldehyde were present in many work-
places. The recent phase ofMMVF produc-
tion is characterized by the use of more
modern production methods as well as dust-
suppressing agents (mainly mineral oil) and
resin binders, with significant reductions in
levels ofrespirable fiberexposure (7).
The annual worldwide production of
MMVFs as of 1985 was in excess of6 million
tons (8). MMVF products release airborne res-
pirable fibers during both their production and
use, and it is estimated that exposure levels of
respirable fibers inglasswool productiongener-
ally have been in the region of0.1 fibers/cm3;
recent exposures in rock wool and slag wool
production are considered to be somewhat
higher (8). Much higher exposures may occur
among end users such as construction workers
when MMVFs are used in confined spaces, as
during application ofinsulation. This parallels
theexperiencewithasbestos inwhich earlycon-
trols over exposure were applied solely in the
production facilities and exposures in the con-
struction/insulation settingwere largely ignored
until the dramatic epidemiologic reports ofthe
1960s and 1970s (9,10).
Mechanisms of Fiber-Induced
Disease
A detailed account offiber pathogenesis at the
cellular, biochemical, and molecular levels is
beyond the scope ofthis article. The study of
the potential mechanisms ofpulmonary health
effects from fibers has been dominated by a
concern for asbestos because ofits much better
demonstrated carcinogenic and fibrogenic
properties, but manyofthe observations about
asbestos have direct relevance or give perspec-
tive to understanding the effects ofMMVFs
and other synthetic fibers. The capacity for
asbestos to induce pulmonary and pleural
fibrosis in humans is indisputable, whereas the
evidence supporting this for MMVFs is lim-
ited. Although all forms ofasbestos are well-
established animal andhuman carcinogens, the
International Agency for Research on Cancer
(IARC) (8) categorized insulation wools as
Class 2b (possibly carcinogenic to humans),
and glass fibers as Class 3 (indeterminate as to
whether they are carcinogenic). Present-day
concerns about the toxicity ofall fibers are
based on principles derived from experience
with the toxicity ofasbestos fibers. In particu-
lar, in vitro and in vivo studies ofMMVFs are
often designed to replicate studies that have
been donewithasbestos fibers (11).
Depositional characteristics, biopersis-
tence, and the chemical composition are
among the most important determinants of
the intrinsic toxicity of any inhaled fiber.
Many studies have attempted to understand
pathogenesis by microscopic detection and
quantification ofdifferent fiber types in dif-
ferent areas of the lung (see section "Lung
Burden Studies"). Respirable fibers ofcon-
cern have an aspect ratio ofat least 3 and an
aerodynamic diameter < 10 pm, correspond-
ing to a measured physical diameter ofless
than approximately 3-4 pm. However rela-
tionships between measured diameters,
shape, length, and aerodynamic diameter are
quite complex as determinants ofpulmonary
penetrance and deposition of fibers (12).
Beyond shape and size, increasing attention
is being paid to particle (fiber) chemistry as a
determinant ofvariables such as dissolution
behavior, ion exchange, sorption properties,
and surface reactivity (13).
Mechanistic studies offiber health effects
have recently proceeded along two major lines:
those demonstrating biochemical mechanisms
by which fibers induce disease, and those
investigating human susceptibility and other
host factors that contribute to or mitigate toxi-
city. New lines ofinvestigation among the lat-
ter with important clinical applications are a
group ofstudies beginning to investigate the
role ofcertain enzyme polymorphisms in
contributing to diseasesusceptibility.
Fibrosis from asbestos and other fibers
appears to arise from a process ofchronic
inflammation associated with the elaboration
and release ofmediators such as lysosomal
enzymes, intermediates ofarachidonic acid
production, proteases, cytokines, growth fac-
tors, and reactive oxygen species (ROS) from
pulmonary macrophages, neutrophils, and
other inflammatory cells. As the inflamma-
tion proceeds, fibroblast proliferation occurs
and excess collagen is deposited in the lung
parenchyma in the area of the offending
fiber. Continued exposure and fibrosis results
in asbestosis (2,14). The ROS, in particular,
hydrogen peroxide, superoxide anion, and
hydroxyl radical, can also be produced in
cell-free systems, and thus presumably by
direct chemical reactions between intrinsic
metals on the fiber surface and extracellular
fluids (15). Among the most prominent
mechanisms hypothesized to account for
fiber carcinogenesis is DNAdamage from the
ROS (15,16).
In recent years a number ofinvestigators
have shown the susceptibility hypothesis to
have some clinical relevance. For instance, it
has been shown that the glutathione S-trans-
ferases (GSTs) conjugate a variety ofreactive,
electrophilic substrates. Deletion ofthe gene
coding for the mu class ofGSTs is associated
with increased risk for mesothelioma (17),
lung cancer (18), and asbestosis (19,20).
LungBurdenStudies
Fiber biopersistence is defined as the retention
offibers in the lung, over time, with regard to
their number, dimensions, surface chemistry,
chemical composition, surface area, and other
physical characteristics (21,22). Long fibers
are generally believed to have more biologic
activity and therefore greater pathogenicity
than short fibers. Experimental studies have
shown that fibers that are most carcinogenic
for the mesothelium have fiberlengths > 8 pm
and diameters < 0.25 pm (23). Asbestos fibers
that tend to split longitudinally thereby pro-
ducing thinner and longer respirable fibers are
more pathogenic according to this hypothesis,
whereas MMVFs (because oftheir brittleness)
tend to split transversely resulting in shorter
fibers of reduced aspect ratio (24). Long
asbestos fibers are cleared less rapidly than
short fibers (25). However, this does not hold
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true for all MMVFs. Although long RCFs
behave in a fashion similar to asbestos fibers
(26), studies ofglass wool fibers reveal that
long fibers actually are cleared more rapidly
than shorter fibers, perhaps because ofdiffer-
ences between intracellular and extracellullar
pH. Thus, although the ability offibers to
induce tumors in lung tissue or serosa is
thought to be related to their biopersistence,
there are often conflicting data and no clear
thresholds (27). These mechanistic
approaches to differentiate fiber toxicity have
parallels to more clinical investigations of
fiber burden in exposed cohorts ofasbestos
and MMVF workers.
Lung burden studies involve the micro-
scopic examination oflung tissue to identify,
localize, and estimate the concentration of
different fiber types in different parts ofthe
lung. Light microscopy, electron microscopy,
and more recently, energy dispersive X-ray
analysis have been used. Although tremolite is
present at a low concentration ofapproxi-
mately 1% in commercial chrysotile, lungs of
workers exposed to chrysotile have a dispro-
portionate amount of tremolite compared
with chrysotile present in the pulmonary
parenchyma at autopsy (28). McDonald et al.
(29) analyzed autopsy specimens from 78
Canadian mesothelioma cases and matched
controls and concluded that therewere signif-
icant differences in amosite, crocidolite, and
tremolite but not chrysotile between the two
groups. The results ofsubsequent studies are
subject to conflicting interpretation, but most
report a better association ofmesothelioma
risk with lung concentrations oftremolite
than chrysotile (30). Since chrysotile appears
to be cleared from the parenchyma more
rapidly than tremolite or other amphiboles,
the concentration oftremolite may actually
be a better exposure (dose) metric for
chrysotile than the lung burden ofchrysotile
itself(31). The paradoxical observation that a
number ofstudies have found higher concen-
trations ofchrysotile than amphiboles in the
pleura, even when amphiboles were the pre-
dominant exposure, limits the relevance of
these parenchymal measurements for delin-
eation ofriskofmesothelioma (32,33).
Green et al. (34) examined lung tissue
from Charleston, South Carolina, chrysotile
textile workers compared with a demographi-
cally matched referent group of autopsy
deaths from the same hospitals and found that
chrysotile levels were 5-fold higher and tremo-
lite levels were 15-fold higher in the workers.
This study estimated lifetime individual
inhalation exposures. Significant positive
correlations were found between lifetime
cumulative exposure to asbestos and total lung
burden of all asbestos fibers, as well as
chrysotile and tremolite fibers individually.
Pulmonary fibrosis was correlated with both
cumulative exposure and the concentration of
asbestos fibers in the lung, although tremolite
provided a better correlation with pathologic
fibrosis. The authors concluded that a com-
ponent offibrosis in these asbestos workers
could be due to asbestos fibers that were sub-
sequently cleared (i.e., chrysotile), which is
consistent with current mechanistic under-
standing ofthe largely irreversible effects of
inflammation in producing fibrosis. The most
likely interpretation of these data is that
tremolite concentrations in lung are a better
metric ofasbestos exposure than chrysotile
concentrations but cannot necessarily be used
to infer differential asbestos pathogenicity. We
agree with Stayner et al. (33) that, for both
technical and biologic reasons, the lung bur-
den studies ofdifferential fiber types do not
clearly support a strong gradient in ability to
cause fibrosis and mesothelioma and offer
insufficient basis for discounting chrysotile as
acause ofeithercondition.
Although previous work with asbestos
indicates that long and relatively thick
asbestos fibers have a tendency to become
asbestos bodies, there are species-specific vari-
ations in the ability of asbestos fibers to
become coated in the lung (35). Studies of
MMVFs in animals indicate that the synthe-
sis of ferruginous bodies depends on fiber
dimensions as well as on the animal model.
Holmes et al. (36) instilled glass fibers into
hamsters and demonstrated partially coated
glass fibers in lung tissue, with the frequency
of the coated fibers varying according the
fiber dimensions. The proportion ofcoated
fibers varied considerably in animals killed at
the same time. Although Davis et al. (37)
found ferruginous bodies in rats exposed to
RCFs, Smith et al. (38) did not find ferrugi-
nous bodies in rats exposed to fiberglass or
RCFs; they did, however, find some ferrugi-
nous bodies in hamsters exposed to the same
MMVFs. Dufresne et al. (39) used a sheep
model of pneumoconiosis to evaluate the
long-term effects ofglass wool, rock wool,
and RCFs on lung tissue. Ferruginous bodies
were not found for any ofthe MMVFs but
were present in sheep exposed to crocidolite
(the positive control group). Thus, evidence
supporting MMVF ferruginous body produc-
tion in animal models is limited, and it is
unlikely that formation offerruginous bodies
from MMVFs could be used as a marker of
exposure to MMVFs.
Human data from electron microscopic
fiber burden analysis of MMVFs suggest
some differences in persistence according to
fiber type. Lung tissue samples from 131
workers in a cohort ofglass, rock, and slag
wool production workers did not show a con-
vincing excess ofany one fiber type compared
to unexposed controls (40). A study by
Sebastien (41) did not yield any evidence for
substantial long-term retention for MMVFs
in the human lung. Roggli (24) examined
lung tissue from three ceramic fiber workers,
one ofwhom had adenocarcinoma of the
lung and parietal pleural plaques. He identi-
fied substantial numbers ofaluminum silicate
fibers that were consistent with RCFs. In
addition, he observed a few ferruginous bod-
ies with RCF cores in one patient. These lim-
ited findings suggest that the RCFs are
deposited in the lung but that other types of
MMVFs, including those more commonly
used, are not persistent in lung tissue.
Clinical and Epidemiologic Data
on Asbestos Health Effects
Nonmalignant Disease
Asbestosis (interstitial fibrosis of the lung
parenchyma) typically has a slow subclinical
course for many years evolving to a sympto-
matic phase with the typical presentation of
interstitial fibrosis: dyspnea, inspiratory
crackles, basilar interstitial opacities, and
physiologic restriction. In the 1990s a num-
ber of studies of highly exposed workers
established that radiographic manifestations
of interstitial fibrosis are more common
among those who smoke (42). At the lower
end ofthe exposure scale, non-occupational
environmental exposure to asbestos in prox-
imity to a factory has been implicated in
some cases ofasbestosis (43).
Over the past 10-15 years, considerable
attention has been focused on the clinical and
physiologic effects ofasbestos-related pleural
disease (44,45). Substantial evidence has
accumulated that pleural fibrosis is associated
with measurable decrements in forced vital
capacity (FVC) and diffusing capacity inde-
pendent ofdetectable fibrosis (byhigh-resolu-
tion computed tomography [HRCT]) or
alveolitis (bybronchoalveolar lavage) (46).
Experience has accumulated with the use
ofcomputed tomography (CT) and HRCT
for determination ofasbestosis and asbestos-
related pleural disease. HRCT is generally
regarded as more sensitive than chest radio-
graphs and conventional CT, and HRCT
findings correlate with restriction, as
described above. Pleural disease can be more
readily distinguished from normal chest wall
structures, and underlying parenchyma can
be imaged in the presence ofextensive over-
lying pleura (47,48). Newer investigations
have begun to score HRCT readings quanti-
tatively, and it is noteworthy that in one
study that had histopathologic comparisons,
the HRCT was normal or near normal in 5
of25 asbestosis cases (4Sf).
The International Labor Office (ILO)
classification of chest radiographs for
pneumoconiosis is the established standard
for epidemiologic study ofthe clinical effects
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ofdusts. Improved imaging techniques such
as HRCT may improve the sensitivity of
readings, particularly at the low end ofthe
spectrum, although the reading ofplain films
by two experienced B readers did comparably
well in one controlled study (50). The chal-
lenge for the future is to integrate use ofCT
or other advances for screening and diagnosis
in a cost-effective manner among the lesser-
exposed cohorts ofthe future.
Mesothelioma
Mesothelioma is a malignant disease ofthe
lining ofthe chest or peritoneal cavity. The
more common pleural mesothelioma classi-
cally presents with dyspnea, chest pain, and
opacification ofone or both lung fields; the
case fatality rate is extremely high, with few
documented survivors and no effective stan-
dard therapy (51).
In the first half of the 20th century
mesothelioma was an exceedingly rare disease,
with background rates in the United States
and Canada for the 1960-1970 period esti-
mated at 2 per million, somewhat higher in
males (52). Case reports in conjunction with
asbestosis began to appear in the 1930s and
1940s, and by 1960 data from South Africa
showed a strong association with asbestos
exposure in miners, their family members,
and other local residents [see McDonald and
McDonald (52) for historical review].
Despite this, debates in the pathology com-
munity questioned the existence ofprimary
malignant mesothelioma into the 1960s (53),
suggesting the possibility ofundercounting in
some retrospective epidemiology based on
clinical or death certificate records from
before the 1970s. The existence ofthis devas-
tating tumor, as well as its very strong rela-
tionship to asbestos exposure, is now
undisputed, although some question the
extent to which chrysotile causes mesothe-
lioma and the lower limits of the
dose-response relationship (54).
TheAmphibole Hypothesis
ofDifferential FiberToxicity
Over the last quarter century it has become
widely acknowledged that crocidolite fiber is
the most potent fiber type for causing
mesothelioma, whereas chrysotile is the most
widely used fiber type. But the relative poten-
cies are controversial, with some, at one
extreme, asserting that the potential for
chrysotile to cause mesothelioma is minimal
(55), and others maintaining that chrysotile
because of its ubiquity and substantial
although lesser toxicity is the predominant
cause ofmesothelioma cases (56). Although
the evidence can be divided into toxicologic
(laboratory) studies, human lung burden
studies, and epidemiologic studies, it is the
latter two that have engendered the greatest
controversy and disagreement. We now turn
to theepidemiologic studies.
In the 1980s, various authors [e.g.,
(57,58)] began to suggest, primarily on the
basis oflaboratorypathologyobservations, that
amphiboles were far more carcinogenic than
chrysotile, and in particular, that carcinogenic
properties ofchrysotile, particularly for
mesothelioma, were due to its contamination
by tremolite fibers. This led to the develop-
ment ofthe "Amphibole Hypothesis" (59),
enabling some to argue that chrysotile is rela-
tively innocuous with respect to its ability to
cause mesothelioma. Ifthis were true, itwould
allow the global economy to safely focus on
strict control ofamphibole exposure while
expanding the use ofchrysotile to take advan-
tage ofits many desirable commercial proper-
ties. These arguments have been updated (2)
and reviewed in detail, with many authors
finding them unpersuasive, largely from an
epidemiologicperspective (33,60-63).
Substantial new epidemiologic data have
emerged in just the past 5 years on the risk
for mesothelioma from chrysotile, with or
without tremolite contamination, and the
nature ofthe dose response for causation of
lung cancerbychrysotile. These are addressed
in detail below.
McDonald and McDonald (64) reported
a nested case-control study ofminers and
millers within subregions ofThetford Mines,
Quebec, Canada. They found odds ratios
(ORs) of2.55 for mesothelioma and 1.98 for
lung cancer (compared to general population
controls) in the central mines area, which has
been reported (on the basis oflimited mea-
surements) to have 4-fold higher contamina-
tion of its commercial chrysotile with
tremolite than the peripheral area (65). They
reported no elevated ORs in the peripheral
(lower but nonzero tremolite) area relative to
a general population comparison group.
Liddell et al. (66) report for the same popula-
tions no increase in the standardrized mortal-
ity ratio (SMR) for lung cancer at < 300
mpcf-years (millions ofparticles per cubic
foot-years)of cumulative exposure, which
they state is much lower than any currently
permitted occupational exposure, although
there are at least issues ofnoncomparability of
the exposure metrics. They reported however,
substantial numbers ofmesotheliomas and
pneumoconiosis deaths at this level, with data
suggestive ofadose response.
McDonald (55) recently reexamined the
so-called asbestos textile mystery, inwhich he
estimates the risks oflung cancer in South
Carolina textile workers to be "perhaps 50
times higher" than in the Quebec miner
cohort, whereas the mesothelioma risk is
similar and relatively low (between 2 and 5
per 1,000). These data are interpreted by the
author to show that chrysotile poses little risk
ofmesothelioma at any exposure level, and a
fairly low risk oflung cancer at environmen-
tal, as opposed to textile-production, levels
ofexposure.
However, additional data have emerged thatchallenge the conclusions ofthese studies
thatchrysotile presents relatively little risk of
mesothelioma. Recently Camus et al. (67)
demonstrated a relative risk of 7.6 for
mesothelioma in women living (but report-
edly notworking with asbestos) in asbestos-
mining towns in Canada compared to other
Canadian communities. There was no com-
parable excess oflung cancer in this non-
worker cohort. The considerable controversy
engendered by this article in terms ofits rela-
tively low risk for lung cancer (when com-
pared to an existing U.S. Environmental
Protection Agency [U.S. EPA] model for
environmentallung cancer riskfromasbestos)
and its relativelyhigh risk for mesothelioma
attributable to environmental exposure,
speaks to thecontinuing lack ofconsensus on
the two issues: thecarcinogenic dose response
forlung cancer from chrysotile exposure and
the presence ofsignificant risk for mesothe-
lioma following even nonoccupational
chrysotile exposure.
Specifically, commentators argue that the
low risk of lung cancer in this non-
occupationally exposed group is most likely
attributable to predominantly nonrespirable
(too large) fibers characteristic ofmining and
milling (production) operations, as well as to
methodologicproblems inherent in the use of
the U.S. EPA model altogether (68,69).
Another criticism ofthehigh risk ofmesothe-
lioma was that some of the women with
mesothelioma mayactually have had occupa-
tional or household bystander exposures to
amphiboles (70,71). Unfortunately, it is true
that explanations for these controversial lung
cancer and mesothelioma findings are specu-
lative (64. A definitive process for resolution
ofsuch competing explanations from obser-
vational data has yet to be identified, and
competinginterpretations ofdata arelikely to
continue because such an observational study
cannot berepeated.
In an important effort to address the
amphibole hypothesis, Smith and Wright
(56) selected for reanalysis or reassessment
published studies with the 25 highest
incidence rates ofpleural mesotheliomas
and examined the fiber-type exposure in
eachstudy.
Oftheir top 10 studies, chrysotile was the
primary exposure in 2 and was part ofmixed
exposure in 6; crocidolite was the primary
exposure in 3 and was part of a mixed expo-
sure in 5 others. Oftheir entire 25 studies,
chrysotile was the main exposure in 8 and
crocidolite in 5 studies. Thus, no cear domi-
nance ofamphibolesemerged.
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Smith and Wright (56) also reanalyzed
data from studies ofgas mask workers, often
cited as supporting the amphibole hypothesis
(72). Because the chrysotile-exposed gas mask
workers had only a 20% excess lung cancer
risk, Smith and Wright (56) concluded that
they must have actually had overall low
asbestos exposure and relied on excess lung
cancers as a marker ofsubstantial exposure to
chrysotile. Others have used a similar argu-
ment to proportionately adjust expected
mesothelioma risk to observed lung cancer
excess (61). Hence, they discount the rela-
tively low mesothelioma rates in gas mask
workers originally attributed to the lack of
potency ofchrysotile and ascribe it to overall
lowexposure.
Finally, Smith and Wright (56) added
additional years offollow-up to a cohort of
asbestos cement workers and found the excess
of mesotheliomas to be 20% for chrysotile
versus 72% for crocidolite, which gave the
latter approximately a 4-fold greater potency
rather than the often-cited 14-fold greater
potency (73). They ultimately conclude that
chrysotile is a potent cause ofmesothelioma
with 25-50% ofthe potency ofcrocidolite.
Because chrysotile accounts for 95-98% of
global asbestos use, they argue that chrysotile
causes more actual mesothelioma cases world-
wide than theamphiboles.
Low-Level Exposure
Cohort studies of workers have amply
documented asbestos-related disease but pro-
vide very limited dose-response information
atlowexposure levels ofambient environmen-
tal health concern. Ofrelevance, Iwatsubo et
al. (74) used a large-scale, population-based
sample to identify 405 hospital-based cases
and controls. Through individual interviews
they generated an exposure metric for each
case andcontrol on the basis oftheprobability
ofexposure, its intensity, and the frequency
and duration. This revealed a dose-response
relationship with an OR of 1.2 (0.8-1.8) for
the low-exposure category versus 8.7
(4.1-18.5) for the high-exposure category,
with the categories corresponding to estimated
cumulative exposures of 0.001-0.49
fibers/mL-year; 0.50-0.99 fibers/mL-year;
1-9.9 fibers/mL-year, and >10 fibers/mL-year.
Although an accompanying commentary
raises some solid methodologic questions
about inadequacies and potential biases in the
retrospective dose-response estimate by a
panel ofexpert industrial hygienists (75), this
study, with its detailed and individual expo-
sure reconstructions, represents a benchmark
for future investigations. It does not, however,
attempt to distinguish exposures according to
fiber type. Theycondude that there is asignif-
icanlt excess ofpleural mesothelioma at levels
below regulatory limits. For example, 5 years
at the current OSHA PEL of0.1 fibers/mL-
year would produce a 4-fold excess of
mesothelioma (74).
Nonasbestos CausesofMesothelioma
Asbestos is clearly the main cause ofmesothe-
lioma and for a period oftime was the only
known cause of this disease. A series of
studies in the late 1970s and early 1980s
demonstrated that certain villages in central
Anatolian Turkey had elevated incidences of
mesothelioma (up to 50% ofdeaths) as well
as pleural and parenchymal chest film abnor-
malities characteristic ofasbestosis (76-78).
Natural exposure from home construction
activities using soil containing a fibrous zeo-
lite known as erionite has been implicated as
the causative agent. It is both fibrogenic and
carcinogenic in animal models. Interestingly,
small amounts ofchrysotile and tremolite
were found in soil from the same region (79).
Conversely, mesothelioma has not been
observed around geologically similar deposits
in the Western United States, although zeo-
lites are not commercially mined in the
United States, as nonfibrous synthetics are
used instead for commercial purposes (80).
Tremolite asbestos has been found in the soil
of inhabited California communities, and
studies to examine relationships with
mesothelioma are underway (81).
IsAsbestosis NecessaryforAsbestos-
InducedLungCancer?
A 1987 article (82) is frequently misinter-
preted as strong support for the idea that
asbestosis is necessary before there is a car-
cinogenic risk from asbestos exposure. The
highly exposed insulation worker study from
which our sample was drawn, with the
requirement that all in our subsample had to
have had a lung tissue sample available,
makes it impossible to sustain such an
unhypothesized generalization about causal-
ity. Also, there are strong arguments against
the hypothesis that fibrosis is a prerequisite
for carcinogenicity. This ties in with some of
the concerns about the amphibole hypothesis.
Early observations finding an excess of
lung cancers in asbestosis cases (83,84) led
some researchers to argue that lung cancer
occurred only in persons with pulmonary
fibrosis. Ifthis were true, it might reflect the
increased susceptibility ofdamaged lung tissue
to neoplasia. Alternatively, the fibrosis may
simply be a marker ofhigh exposure or ofthe
process ofROS generation, as described previ-
ously. However, some recent studies have doc-
umented a significant excess oflung cancer
incidence in workers who have no radio-
graphicevidence offibrosis. Hughes andWeill
(85) studied a group with asbestos exposure
but no radiographic fibrosis and no significant
excess oflung cancer, reporting that asbestosis
was necessary. Jones et al. (86) studied 271
lung cancer patients and 678 referents and
reported an OR of 1.56 [95% confidence
interval (CI):1.02-2.39] even in workers with
an ILO reading of0/1. Case and Dufresne
(70) studied the autopsyrecords andworkhis-
tories of 111 Quebec chrysotile miners and
millers and concluded that the community
pathologists' diagnoses ofasbestosis seemed
arbitrary, and were not sensitive and effective
predictors of lung cancer. Egilman and
Reinert (87) reviewed 1 1 epidemiologic
studies as well as histologic studies and con-
cluded that these are all consistent with the
hypothesis that asbestosis and lung cancer are
two distinct pathologic processes with the
samedose-related causative agent.
One interesting study oflung cancer has
shown that mutations of the k-ras gene at
codon 12 in lung cancer ofasbestos-exposed
individuals occurred independently of the
radiographic presence ofinterstitial fibrosis,
suggesting that the carcinogenic process, pre-
sumablydependent on some ofthe biochemi-
cal genotoxic mechanisms explained above,
does not require that the inflammatory
process advance to the point ofproducing
visible scarring (88).
Controversy remains about the extent to
which idiopathic pulmonary fibrosis is a risk
for lung cancer (89), and ifso, whether the
risk is due to radiographically evident lesions
or to the underlying inflammatory process.
Despite being cleared from parenchyma
sooner than amphiboles, chrysotile may well
persist long enough to influence a carcino-
genic process through generation ofROS or
other mechanisms previously discussed.
Many other human carcinogens, including
ionizing radiation and benzene, do not
require years ofresidence time to exert their
neoplastic effects and are not identified in
necropsy tissue with the tumors they cause.
At this point there is insufficient evidence to
conclude that pulmonary fibrosis (asbestosis)
is a necessary antecedent ofcarcinogenic risk
from asbestos.
Health Effects of MMVFs
ChronicAnimal Bioassays ofMalit
andNonmaignant Disease
Animal studies of the toxicity of asbestos
fibers indicate that there are several potential
mechanisms for fiber-induced carcinogenesis.
There is some evidence that asbestos fibers
generate free radicals that cause DNAdamage,
interfere with mitosis, stimulate proliferation
oftarget cells, and provoke chronic inflamma-
tory reaction, resulting in the release ofROS,
cytokines, and growth factors (15,16). We did
not consider bioassays with respect to asbestos
because of the widely accepted status of
asbestos as a cause offibrosis and cancer in
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humans; however animal bioassays remain
pertinent to consideration ofthe fibrogenicity
andcarcinogenicity ofMMVFs.
The cytotoxicity of MMVFs has been
examined in several studies. Luoto et al. (90)
showed that MMVFs caused a modest but
dose-dependent release of lactic dehydro-
genase from alveolar macrophages, activated
the release ofROS, and caused hemolysis in
sheep erythrocytes. In vitro studies by
Ruotsalainen et al. (91) examined the effects
of glass wool, rock wool, and RCFs on
human polymorphonuclear leukocytes
(PMNLs) and erythrocytes. MMVFs did not
affect theviability ofPMNLs (as measured by
the trypan blue exdusion test) or induce cell
hemolysis, unlike chrysotile and quartz,
which caused dose-dependent increases in lac-
tic dehydrogenase and induced hemolysis.
However, there is evidence that MMVFs
caused a dose-dependent activation ofROS
in human PMNLs, with RCFs being the
most active inducer of ROS production
among the MMVFs tested. Variation in fiber
length did not modify the ability ofMMVFs
to induce ROS production. It is postulated
that MMVFs activate ROS production,
thereby causing DNA damage, cell injury,
andeventually cell death.
The ability offibers to induce tumors in
lung tissue or serosa is generally thought to be
related to their biopersistence, although, as
we have discussed with chrysotile, this can be
complex. Solubility and clearance studies of
MMVFs in animal lung tissue indicate that in
general, glass fibers are more soluble than
rock wool, whereas RCFs are the most
durable ofMMVFs (92. However, studies of
even the most durable MMVFs such as
alumino-silicate RCFs show surface morpho-
logic alterations after in vivo residence of
6 months in rat lungs, suggesting that RCFs
show signs ofdissolution and are physically
deared from the lung (93).
Animal experiments have been used in an
attempt to determine whether exposure to
MMVFs has health effects similar to asbestos
exposure. Several studies have clearly demon-
strated that MMVFs are highly carcinogenic
when injected into the pleural and peritoneal
cavities (11), whereas long-term rodent
inhalation studies ofMMVFs have yielded
conflicting findings with respect to produc-
tion oflungfibrosis and cancer (27,94).
Inhalation studies with glass wool, glass
fiber, and slag wool are generally reported
negative for fibrosis. Minimal fibrosis was
observed in rock wool studies at the highest
exposures, but no significant excess oflung
tumors was reported (95). Ellouk and
Jaurand (11) pooled data on glass wool
inhalation studies and found a statistically
significant increase in lung tumor develop-
ment in rodents, whereas studies with slag
wool, rock wool, and glass microfibers were
largely negative. Although intrapleural RCF
injection studies for mesothelioma were
largely negative, intraperitoneal inoculation
studies showed statistically significant
increases in tumors for glass wool, glass
microfibers, and RCFs (11).
Inhaled RCFs induced lung tumors and
mesotheliomas in both rats and hamsters,
although with some inconsistencies between
studies. In one study, inhalations ofRCFs in
rats and hamsters were negative for lung
fibrosis or tumor (94). Mesothelioma was
observed in hamsters, but this did not achieve
statistical significance. In a subsequent RCF
study, however, the results were positive for
lung fibrosis and mesotheliomas in both rats
and hamsters as well as for lung cancer in rats
(6). The latter study also demonstrated a
dose-response relationship for lung fibrosis.
The differences in the results of the two
studies have been attributed to the slightly
larger diameter RCFs (4), hence reduced fiber
penetration and retention, in the initial study
bySmith et al. (94).
Because continuous glass filament fibers
tend to have larger diameters, typically
4-7 pm, and were negative in injection
studies, they are generally thought to have
minimal potential to be carcinogenic.
Sufficient animal bioassays for carcinogenicity
have not been conducted to completely
exclude this possibility, and IARC considers
these fibers unclassifiable with respect to
carcinogenicity (8.11).
Clinical andEpidemiologic Studies
ofNonmalignant Disease
Rock and slagwool have been produced since
the 1800s and glass fibers since the 1930s,
with remarkably few reports ofpulmonary
disease due to MMVF exposure. The preva-
lence of nonspecific respiratory diseases
(chronic obstructive pulmonary disease,
emphysema, chronic bronchitis, and asthma)
has been examined in a number ofstudies of
MMVF workers. Even though there are varia-
tions in the study designs, the results have
been largely negative (96,97). A study of
ceramic fiberworkers did not find any associ-
ation between chronic bronchitis or wheezing
and cumulative exposure to respirable fibers.
However, there was a significant decrease in
the forced expiratory volume and forced
mid-expiratory flow related to cumulative
fiber exposure in smokers (98). This study
concluded that cumulative exposure to res-
pirable ceramic fibers may contribute to air-
ways obstruction by promoting the effects of
cigarette smoke. A recent study by Lockey
et al. (99) showed a significant decrease in
FVC among workers employed in RCF
production jobs prior to 1980 that did not
persist with analysis ofsubsequent production
years. The reduction in RCF exposure levels
after the 1980s was postulated to be responsi-
ble for eliminating any further effect ofRCFs
on pulmonary function. Lemasters et al.
(100) also observed a significant decrease in
FVC in men who smoked and manufactured
RCFs. However, in women a significant
decrease in FVC was found only in nonsmok-
ers. The implications ofthis intriguing sex
difference in response to combined RCF
exposure and smoking require replication and
further investigation.
Several studies examined chest radio-
graphs ofoccupationally exposed individuals,
and the results have been largely negative for
evidence ofpneumoconiosis (97,98,101,102).
Weill et al. (103) reported radiographic find-
ings ofsmall irregular opacities (ILO grades
1/0 to 1/1) in 3% ofglass, slag, and rock
wool production workers during an initial
cross-sectional survey in 1983. This studywas
not controlled and was subject to bias from a
survivor effect. A follow-up survey of the
same workers in 1993 (97) did not find any
significant effect of MMVF exposure com-
pared to local blue-collar worker controls and
there was also no apparent progression of
radiographic opacities in the MMVF workers.
A study offiberglass workers (end users)
by Kilburn et al. (104) reported a 13% overall
prevalence ofpleural abnormalities and small
irregular opacities, profusion 1/0 to 2/1, due
to fiberglass exposure. Possible limitations of
the study were that there was insufficient
information on individual historical asbestos
exposure, as asbestos fibers were reportedly
present in the production facility (105), and
most of the chest film readings were not
blinded to exposure. Using the ILO dassifica-
tion, Trethowan et al. (98) reviewed the chest
films ofemployees ofseven European plants
that manufacture ceramic fibers. Small opaci-
ties profusion of0/1 or greater were found in
13% ofthe radiographs. Profusion scores of
1/1 or greater were found in 18 of592 (about
3%), 11 ofwhom had reported confounding
exposures to other dusts. The prevalence of
small opacities increased with age, smoking,
and previous exposure to asbestos and impor-
tantly was not related to cumulative exposure
to ceramic fibers. To date, the cumulative evi-
dence ofradiographic changes indicative of
pulmonary interstitial fibrosis in MMVF
workers is inconsistent.
Pleural plaques have been reported in a
cohort ofRCF manufacturing workers in an
ongoing respiratory morbidity and mortality
study in the United States. Twenty of652
(3.1%) workers were found to have pleural
changes (pleural plaques and thickening) on
chest films. The prevalence was highest
(12.5%) in those who began their production
jobs more than 20 years ago, for an OR of
9.5. Additionally, 5 of 19 workers (26.3%)
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with more than 20 years total employment in
RCF production jobs had pleural plaques on
chest films, for an ORof22. A dose-response
relationship with cumulative estimated expo-
sure was also demonstrated. A nested
case-control interview study showed that
asbestos exposure did not account for the
observed association between plaques and
RCF exposure. There was no increase over
historical control levels (0.5%) for small
irregular opacities that would be indicative of
lung fibrosis (99). It is noteworthy that
pleural abnormalities were also observed in
16 of592 films ofceramic fiberworkers (two
ofwhom had experienced previous exposure
to asbestos) in the European study by
Trethowan et al. (98). The pleural changes
were related to age but not independently to
estimated ceramic fiber exposure. Thus,
although the evidence to date does not clearly
indicate that radiographic changes of pul-
monary interstitial fibrosis are clearly associ-
ated with MMVFs, there is substantial
evidence in at least one cohort that RCFs
caused pleural plaques. The fact that the
worst degree offibrosis reported in any indi-
vidual from a cohort is 2/1 provides substan-
tial reassurance that MMVFs are not as likely
as asbestos or silica to cause morbidity from
pulmonaryfibrosis.
Epidemiologic Evidence That
MMVFs Cause Malignancy
HumanStudies
Several large population-based mortality
studies of MMVF workers have been pub-
lished. Enterline and Marsh (106) conducted
a study of 7,049 MMVF workers in the
United States. Even though SMRs were ele-
vated for most major causes of death for
workers with more than 20 years since expo-
sure (4,120 workers), none of the observed
excesses achieved statistical significance. In
addition, there was no evidence of excess
malignant or nonmalignant respiratory dis-
ease associated with fiberglass exposure. A
Canadian studyby Shannon et al. (107) actu-
ally found a reduced risk (SMR = 78) in glass
fiber workers. There was a statistically
insignificant increase in lung cancer deaths in
this cohort. These results were supported by a
subsequent study of glass filament textile
workers in Ontario, Canada (108).
Bertazzi et al. (109) found an increased
risk oflaryngeal cancer (based on four deaths)
in a cohort of 1,098 glass wool and continu-
ous filament fibers workers in Italy. The risk
for laryngeal cancer was highest in persons
employed before 25 years ofage, with at least
15 years offiber exposure, and with onset of
exposure before 1960. The authors could not
attribute the excess risk observed to known
confounders for laryngeal cancer, and no
other excess risks for cancer or mortality were
observed in this study.
A study of MMVF workers in Finland
did not show any any significant difference in
mortality or excess cancer risk (110). Gardner
et al. (111) examined cancer mortality in a
glass wool plant in the United Kingdom and
observed a borderline increased risk oflung
cancer among the workers compared to
national cancer rates. However, the excess risk
had little relationship to the length and dura-
tion ofemployment or to the level ofexpo-
sure to MMVFs. Claude and Frentzel-Beyme
(112) reported similar findings in a study of
rockwool factoryworkers in Germany.
IARC conducted a historical cohort study
ofmortality ofapproximately 25,000 MMVF
workers in seven European countries (7). This
studyfound an increase in lung cancer mortal-
ity risk (SMR = 128) in rock/slag wool work-
ers. The risk increased as the time since first
exposure to rock/slag wool production
increased. Exposures such as smokingand pre-
vious employment were considered unlikely
explanations for the excess risk observed. The
highest lung cancer mortality risk (SMR =
223) was observed in the early technological
phase of production during which worker
exposure to high levels ofrespirable fibers as
well as arsenic (component ofslag) and poly-
cyclic aromatic hydrocarbons from furnace
fumes occurred in the production facilities.
Excess mortality was not observed in workers
employed in the late technological phase of
mineral fiber production when production
changes reduced exposures. This studydid not
find an increased risk ofmortality from non-
malignant respiratory disease or from pleural
tumors. The findings in the IARC study (7)
are supported by Boffetta et al. (113), who
also reported that workers employed in the
early technologic phase ofproduction, partic-
ularly rock/slag wool workers, were at higher
risk oflung cancer mortality than those in
other categories.
More recently, Boffetta et al. (114)
reported follow-up data on the IARC cancer
mortality study ofEuropean MMVF workers.
The SMR for lung cancer was significantly
increased at 134 for rock/slag wool workers,
although not elevated compared to local mor-
tality rates. The associations between lung
cancer risk and time since first exposure as well
as duration ofemploymentwere maintained as
in the earlier study, although the trend for
increased cancer risk according to the techno-
logical phase ofproduction was less marked.
This study also reported five deaths from
mesothelioma, although the authors did not
feel that this represented a clear excess over
relevant national rates.
Marsh et al. (115) conducted a follow-up
study ofover 16,000 mineral fiber workers in
the United States. They observed a small but
statistically significant excess of malignant
neoplasms (SMR= 108.3) and respiratory
tract cancer (SMR = 112.1) in the workers.
Mineral wool fiber workers had higher respi-
ratory tract cancer risks compared to glass
wool/filament workers. This study reported 4
mesotheliomas. Wong et al. (116) and
Chiazze et al. (96) conducted case-control
studies oflung cancer and MMVF exposure,
and both studies reported no significant asso-
ciation with exposure, although, as expected,
associations were foundwith smoking.
In summary, MMVFs are a diverse group
ofsynthetic fibers that have biologic activity
in both animal and human lung tissue.
MMVFs generally differ from asbestos fibers
in that a lesser proportion of them are res-
pirable and the inhaled fibers are less durable
than asbestos fibers. Nonetheless, there is
convincing evidence that some ofthese fibers,
in particular RCFs, are capable of inducing
lung tumors in rats and mesotheliomas in
hamsters. The data provided by mortality
studies are not sufficient to conclude that
rock/slag wool causes an excess in the risk of
lung cancer, nor do they support compla-
cency with respect to carcinogenicity. Many
mineral fibers are respirable and may have
contributed to increased lung cancer risk,
possibly in combination with other work
exposures, particularly in the early technolog-
ical phases of mineral wool production.
Recent convincing studies have demonstrated
the occurrence of pleural plaques in RCF
workers without concomitant interstitial
fibrosis. It has yet to be determined if these
pleural changes augur a risk for human
mesothelioma. Long-term follow-up studies
ofthe RCF worker cohorts mayprovide these
answers over the next decade. At the present
time, significant human carcinogenic risk
from any inhaled MMVFs is neither clearly
established nor refuted.
NylonFlock-AssociatedInterstitial
LungDisease
In 1998, David Kern and colleagues from
Brown University in Providence, Rhode
Island, described an occurrence of radio-
graphically visible interstitial lung disease that
occurred among workers at a Rhode Island
nylon flocking plant (117). There was both
radiographic and functional improvement,
although not complete resolution, after cessa-
tion ofwork. A subsequent pathologic review
concluded that the pathologic findings, a
lymphocytic bronchiolitis and peribronchioli-
tis with lymphoid hyperplasia represented by
lymphoid aggregates, were distinctive com-
pared with known lung conditions. Although
not the only inhalation exposure in the plants
investigated, the preliminary concern is that
flock, from cut or pulverized fiber (synthetic
or natural), used to produce a velvetlike coat-
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ing on fabrics, is the causative agent.
Preliminary reports of some toxicologic
studies support that ultrafine respirable
fibrous fragments ofnylon can cause acute
inflammatory lung injury in rodents (118).
The popularity ofthe processes used in this
plant suggests that more cases of "flock
worker's lung" are likely to be identified.
Additional organic fibers such as para-aramid
fibrils, used in the manufacture ofbulletproof
vests, are being studied in animal models for
toxicity. One study reported much less reten-
tion and inflammation than long chrysotile
fibers (119); no human data are available.
Regulatory Policiesfor
Exposure to Fibers and
Research Recommendations
As of 1999, asbestos use was banned in
Sweden, Norway, Denmark, the Netherlands,
Finland, Germany, Italy, Belgium, France,
Austria, Poland, and Saudi Arabia. Groups of
knowledgeable scientists have called for a
worldwide ban on asbestos mining and use
(120,62). This effort is based on estimates of
residual lifetime risk for lung cancer (5/1000)
and asbestosis (2/1000) (1) at the present U.S.
standard of 0.1 fibers/mL and the fact that
few ifany developing countries are expected
to achieve such lowlevels ofexposure (121).
The U.S. OSHA PEL for asbestos is based
on fibers > 5 mm long with a 3:1 aspect ratio,
counted by phase-contrast light microscopy.
For manyyears the PEL was 5 fibers/cc, but it
has been progressively reduced to 2 fibers/cc
in 1976, 0.2 fibers/cc in 1986, and 0.1
fibers/cc in 1994. The American Conference
of Governmental Industrial Hygienists lists
different threshold limit values for different
fiber types (2 fibers/cc for chrysotile vs 0.5
fibers/cc for amosite and 0.2 fibers/cc forcroci-
dolite). OSHA does not recognize this distinc-
tion. There are no U.S. standards for MMMFs
at this time. Sweden imposes an exposure limit
forglass fibers of2 fibers/cc (8).
Different nations have developed various
regulatory and economic policies for exposure
to asbestos and MMMFs. These range from
banning ofthe former and encouragement of
the latter, to increased use of asbestos and
only tentative use ofMMMFs. Most devel-
oped nations are at the former end of the
spectrum and many developing nations are in
the latter category, largely as a function of
cost. Where asbestos is used, different coun-
tries (and indeed different agencies within
countries) advocate different standards for
workplace and ambient exposure. Central to
the controversy over asbestos-related disease
are observations ofvery different rates ofdis-
ease in different parts ofthe world, related to
different fiber types and industrial activities.
Modern techniques of exposure assessment
should be applied to better quantify the
exposures in these settings (at least, where
exposures are ongoing), particularly with
regard to differential distributions ofparticle
size and shape. This approach may also con-
tribute to resolution ofcontroversy about rel-
ative risks of different types of MMVFs.
Discrepancies in the epidemiologic literature
must be examined more critically with
respect to the type, intensity, constancy, and
duration ofexposure.
A systematic transnational study of the
impact ofthese policies on the uses, exposure,
and health effect consequences of fibers
appears overdue. Where policies change, uses
and exposures change, affording experimental
opportunities to study the impacts ofexpo-
sure on health consequences.
In some ways we are at a crossroads with
respect to research into the health effects of
fibers. In the developed nations powerful new
advances are being made in exposure assess-
ment and in basic toxicology, especially as
applied to susceptibility. These advances,
coupled with coherent epidemiologic designs,
promise a more fundamental understanding,
as well as a personalized risk assessment for
fiber toxicity. Many inconsistencies in the
current epidemiologic database may be elimi-
nated ifprospective studies ofexposed indi-
viduals can be mounted with the new and
developing tools to look at variations in indi-
vidual responses to fibers and other toxicants.
With increasing use and new applications
of asbestos in developing nations, there are
ample opportunities to initiate new prospec-
tive cohort studies taking advantage of new
research technologies. However, ethical
concerns of such investigations must be
addressed carefully because of the well-
documented hazards of asbestos. Although
some researchers feel that education and
interdiction are a higher priority than further
investigation, the fact remains that exposures
are presently occurring.
Although new information about cell
signaling involving free radicals, growth fac-
tors, and cytokines may yet identify interven-
tions that can abort or retard the fibrotic
process, the situation is more than comple-
mented by the molecular epidemiology
approach toward differential human
responses to fibers. The latter seems a more
direct approach, well-rooted in clinical expo-
sure issues, toward identification of critical
pathways of disease and development of
responses. This is a rapidly expanding
research area throughout environmental med-
icine. Although in terms offibers, research
has largely been limited to asbestos, it will
greatly augment our understanding of the
variation in response to other mineral fibers
as well. To an increasing extent, health effects
are dealt with through the surrogate of risk
assessment. Changing mechanistic and expo-
sure models may alter how risk assessments
for both asbestos and MMVFs should be
done (122) as will the incorporation into risk
assessments ofsusceptibility factors based on
polymorphisms orother characteristics.
Epidemiologic studies have provided
much insight into the pathogenicity and car-
cinogenicity ofasbestos. Inconsistent results
among studies, however, point to the
omnipresent need to better characterize expo-
sures and vulnerability. Continued tracking
ofthe few long-term cohorts and the study of
additional cohorts of people exposed to
asbestos under different scenarios will play
important roles in further defining the risks
from asbestos. Fiber types and sizes, as well as
intensity and duration ofexposure to these
fibers are obvious contributors to disease, yet
practical exposure levels below which there is
no appreciable riskhave yet to be defined.
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